{"date":"2025-10-17","count":13,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4178-2025-10-17-1825-1670y85","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-10-17","time":"18:25:11","subject":"代重要子公司台灣永生公告董事會(代行股東會職權)解除董事競業禁止之限制","clause":"第22款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-10-17 18:25，「代重要子公司台灣永生公告董事會(代行股東會職權)解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2025-10-17-1825-1iesuqu","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-10-17","time":"18:25:04","subject":"代重要子公司台灣永生公告會計主管異動案","clause":"第11款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-10-17 18:25，「代重要子公司台灣永生公告會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2025-10-17-1824-bsfxdj","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-10-17","time":"18:24:56","subject":"公告本公司會計主管異動案","clause":"第11款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-10-17 18:24，「公告本公司會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-10-17-1648-1c00pfs","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-10-17","time":"16:48:38","subject":"本公司受邀參加寬量國際主辦之「18th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊。","clause":"第30款","fact_date":"2025-10-21","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-10-17 16:48，「本公司受邀參加寬量國際主辦之「18th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2025-10-17-1631-6pkpco","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2025-10-17","time":"16:31:28","subject":"公告本公司董事會追認修訂114年度第一次員工認股權憑證發行及認股辦法","clause":"第9款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2025-10-17 16:31，「公告本公司董事會追認修訂114年度第一次員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-10-17-1609-1elc2s9","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-10-17","time":"16:09:06","subject":"公告本公司114年第三季財務報告董事會預計召開日期為114年10月27日","clause":"第31款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-10-17 16:09，「公告本公司114年第三季財務報告董事會預計召開日期為114年10月27日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-10-17-1559-5n89cp","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-10-17","time":"15:59:18","subject":"更正114年9月份背書保證申報資訊","clause":"第51款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-10-17 15:59，「更正114年9月份背書保證申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-10-17-1552-1nsksc0","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-10-17","time":"15:52:13","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"第53款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-10-17 15:52，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-10-17-1535-1v20vp9","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-10-17","time":"15:35:28","subject":"公告本公司董事會決議辦理現金增資發行新股案","clause":"第9款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-10-17 15:35，「公告本公司董事會決議辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-10-17-1535-1vhu1xi","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-10-17","time":"15:35:06","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-10-17 15:35，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-10-17-1534-ys57mt","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-10-17","time":"15:34:58","subject":"114年第三季財務報告董事會預計召開日期為114年10月27日","clause":"第31款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-10-17 15:34，「114年第三季財務報告董事會預計召開日期為114年10月27日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-10-17-1529-maoyoz","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-10-17","time":"15:29:14","subject":"公告本公司董事會決議通過財務長任命案","clause":"第8款","fact_date":"2025-10-17","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-10-17 15:29，「公告本公司董事會決議通過財務長任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-10-17-1431-9it9jz","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-10-17","time":"14:31:25","subject":"代重要子公司鼎晉生技股份有限公司公告取得會計師內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-10-17 14:31，「代重要子公司鼎晉生技股份有限公司公告取得會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}